Evidence map›Paper›PMID 41225187›Full record

ArticleOncogene2025

Chaperone-mediated autophagy controlling VEGFR1 degradation contributes cross talk between breast cancer cells and endothelial cells triggering tumorigenesis via the VEGF-VEGFR2 axis.

Sha Chen, Li Xiang, Meng He, Qi Han, Yang Zhang, Mingzhen Yang, An Chen, Jiqin Lian, Shuhui Li

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sha ChenLaboratory Sciences, Department of Clinical Biochemistry, Third Military Medical University (Army Medical University), Shapingba District, Chongqing, PR China.ORCID 0000-0002-1807-1179
Li XiangLaboratory Sciences, Department of Clinical Biochemistry, Third Military Medical University (Army Medical University), Shapingba District, Chongqing, PR China.
Meng HeLaboratory Sciences, Department of Clinical Biochemistry, Third Military Medical University (Army Medical University), Shapingba District, Chongqing, PR China.
Qi HanLaboratory Sciences, Department of Clinical Biochemistry, Third Military Medical University (Army Medical University), Shapingba District, Chongqing, PR China.
Yang ZhangLaboratory Sciences, Department of Clinical Biochemistry, Third Military Medical University (Army Medical University), Shapingba District, Chongqing, PR China.
Mingzhen YangLaboratory Sciences, Department of Clinical Biochemistry, Third Military Medical University (Army Medical University), Shapingba District, Chongqing, PR China.
An ChenLaboratory Sciences, Department of Clinical Biochemistry, Third Military Medical University (Army Medical University), Shapingba District, Chongqing, PR China.
Jiqin LianLaboratory Sciences, Department of Clinical Biochemistry, Third Military Medical University (Army Medical University), Shapingba District, Chongqing, PR China.ORCID 0000-0002-8708-6171
Shuhui LiLaboratory Sciences, Department of Clinical Biochemistry, Third Military Medical University (Army Medical University), Shapingba District, Chongqing, PR China. suhuili757@tmmu.edu.cn.ORCID 0009-0004-8981-2167

Funding

China Postdoctoral Science Foundation 2022MD713710Chongqing Municipal Education Commission (Chongqing Municipality Education Commission) KJQN202200458Chongqing Municipal Human Resources and Social Security Bureau (Human Resources and Social Security Bureau of Chongqing) 2021XM3063Chongqing Science and Technology Commission (Chongqing Science and Technology Commission, Chongqing People's Municipal Government) CSTB2022NSCQ-MSX1097National Natural Science Foundation of China (National Science Foundation of China) 81472481National Natural Science Foundation of China (National Science Foundation of China) 82072946
6 · The paper itself

Abstract

The reciprocal cross talk between breast cancer cells and the endothelial cells, through the secretion of growth factors, plays a vital role in angiogenesis and tumorigenesis. We previously demonstrated that chaperone-mediated autophagy (CMA) promotes breast cancer tumorigenesis. However, whether the cross talk between cancer cells with endothelial cells plays a role in CMA-mediated breast tumor tumorigenesis is unknown. We discovered that the conditioned medium (CM) from breast cancer cells with high CMA activity promoted tube formation of endothelial cells (ECs) via the VEGF-VEGFR2 axis. High CMA activity directly promoted angiogenesis of endothelial cells via the VEGF-VEGFR2 axis. The CM from ECs with high level CMA activity accelerated survival and migration of breast cancer cells in vitro via the VEGF-VEGFR2 axis. Co-injection of breast cancer cells mixed with ECs with high level CMA activity trigged angiogenesis and accelerated tumorigenesis in vivo. CMA activity and microvessel numbers were positively correlated with VEGF-VEGFR2 axis between paired breast tumor and normal adjacent tissue. CMA, a highly selective lysosome-dependent degradation process directly degrades VEGFR1 which can serve as a competitively regulatory factor for VEGFR2 regulating its signaling. Our study showed that the cross talk between breast cancer cells and endothelial cells induced by CMA -mediated degradation of VEGFR1 triggers angiogenesis and tumorigenesis via the VEGF-VEGFR2 axis.

Indexed as

Breast NeoplasmsCarcinogenesisChaperone-Mediated AutophagyEndothelial CellsVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-1Vascular Endothelial Growth Factor Receptor-2AnimalsCell Line, TumorFemaleHumansHuman Umbilical Vein Endothelial CellsMiceNeovascularization, PathologicProteolysisSignal TransductionFLT1 protein, humanKDR protein, humanVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-1Vascular Endothelial Growth Factor Receptor-2VEGFA protein, human

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.